Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Treasury Shares (2022 - 2025)

GoHealth (GOCO) has disclosed Treasury Shares for 4 consecutive years, with $9.4 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 125.81% to $9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Dec 2025, up 125.81% year-over-year, with the annual reading at $9.4 million for FY2025, 125.81% up from the prior year.
  • Treasury Shares hit $2.8 million in Q4 2025 for GoHealth, up from $449000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.8 million in Q4 2025 to a low of $11000.0 in Q1 2022.
  • Historically, Treasury Shares has averaged $402133.3 across 4 years, with a median of $262000.0 in 2024.
  • Biggest five-year swings in Treasury Shares: surged 680.39% in 2024 and later skyrocketed 38.81% in 2025.
  • Year by year, Treasury Shares stood at $345000.0 in 2022, then surged by 665.22% to $2.6 million in 2023, then skyrocketed by 57.2% to $4.1 million in 2024, then surged by 125.81% to $9.4 million in 2025.
  • Business Quant data shows Treasury Shares for GOCO at $9.4 million in Q4 2025, $9.3 million in Q3 2025, and $9.2 million in Q2 2025.